Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
ModivCare Inc is a medical care facilities business based in the US. ModivCare shares (MODV) are listed on the NASDAQ and all prices are listed in US Dollars. ModivCare employs 20,200 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $88.43 |
|---|---|
| 52-week range | $80.55 - $211.94 |
| 50-day moving average | $97.43 |
| 200-day moving average | $126.81 |
| Wall St. target price | $161.67 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.79 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $88.43 from 2022-07-01
| 1 week (2022-06-24) | -1.06% |
|---|---|
| 1 month (2022-06-03) | -9.77% |
| 3 months (2022-04-01) | -26.49% |
| 6 months (2022-01-03) | -39.29% |
| 1 year (2021-07-02) | -48.88% |
|---|---|
| 2 years (2020-07-02) | 11.34% |
| 3 years (2019-07-03) | 54.38% |
| 5 years (2017-06-30) | 74.73% |
Valuing ModivCare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ModivCare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ModivCare's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0984. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ModivCare's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
ModivCare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $162.7 million.
The EBITDA is a measure of a ModivCare's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.1 billion |
|---|---|
| Operating margin TTM | 4.44% |
| Gross profit TTM | $412.6 million |
| Return on assets TTM | 3.22% |
| Return on equity TTM | -6.24% |
| Profit margin | -1.18% |
| Book value | $26.77 |
| Market capitalisation | $1.2 billion |
TTM: trailing 12 months
We're not expecting ModivCare to pay a dividend over the next 12 months.
ModivCare's shares were split on a 1:3 basis on 31 January 2021. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ModivCare shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for ModivCare shares which in turn could have impacted ModivCare's share price.
Over the last 12 months, ModivCare's shares have ranged in value from as little as $80.55 up to $211.94. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ModivCare's is 0.7405. This would suggest that ModivCare's shares are less volatile than average (for this exchange).
ModivCare Inc. , a technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and patients. The company operates through four segments: Non-Emergency Medical Transportation (NEMT), Personal Care, Remote Patient Monitoring (RPM), and the Matrix Investment. The NEMT segment offers contact center management, network credentialing, claims management, and non-emergency medical transport management services for Medicaid or Medicare eligible members, whose limited mobility or financial resources hinder their ability to access necessary healthcare and social services. The Personal Care segment provides bathing, personal hygiene, grooming, oral care, dressing, medication reminders, meal planning, preparation and feeding, housekeeping, transportation services, prescription reminders, and assistance with dressing and ambulation services through placing non-medical personal care assistants, home health aides, and skilled nurses primarily to Medicaid patients in need of care monitoring and assistance in performing daily living activities, including senior citizens and disabled adults. The RPM segment offers personal emergency response systems, vitals monitoring, medication management, and data-driven patient engagement solutions. The Matrix Investment segment provides in-home and on-site care services, as well as a fleet of mobile health clinics that offers community-based care with advanced diagnostic capabilities and care options.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.